NEO

NeoGenomics (NEO)

NeoGenomics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NEO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	05:08	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NEO	NeoGenomics Inc
2024/06/13	21:00	Business Wire	Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/06/05	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/28	21:05	Business Wire	NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management	NASDAQ:NEO	NeoGenomics Inc
2024/05/25	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NEO	NeoGenomics Inc
2024/05/18	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/15	10:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/15	10:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/15	10:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/15	10:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/05/15	10:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/04/30	20:30	Business Wire	NeoGenomics Reports First Quarter 2024 Results	NASDAQ:NEO	NeoGenomics Inc
2024/04/18	20:05	Business Wire	NeoGenomics Announces Senior Leadership Promotions	NASDAQ:NEO	NeoGenomics Inc
2024/04/09	20:00	Business Wire	NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:NEO	NeoGenomics Inc
2024/03/27	21:30	Business Wire	NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	NASDAQ:NEO	NeoGenomics Inc
2024/03/20	20:00	Business Wire	NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	NASDAQ:NEO	NeoGenomics Inc
2024/03/07	06:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/05	07:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NEO	NeoGenomics Inc
2024/03/01	21:05	Business Wire	NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc
2024/02/28	06:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NEO	NeoGenomics Inc